The median age and serum prostate-specific antigen (PSA) levels of the 157 patients with prostate cancer were 68 years (range, 48–76 years) and 7.05 ng/mL (range, 2.42–74.2 ng/mL), respectively (Table 1). This evidence concerns the gene KLK3 and prostate cancer.